Reverse-engineering artificial intelligence

India’s patent laws allow for reverse-engineering of certain technologies. A prime example of this reverse-engineering is in the pharmaceutical space, where Indian pharma companies are allowed to reverse-engineer drugs, especially life-saving ones. These drugs may have been developed by pharma majors in other parts of the world—and then introduced into western markets—after India-based outsourcing firms had helped them out with clinical trials, data gathering and reporting to the US Food and Drug Administration (FDA) or its equivalent to get these drugs passed. Indian courts have continued to allow such reverse-engineering of drugs—famously prompting Bayer AG’s then CEO Martin Dekkers to say at a conference a few years ago, “We did not develop this medicine for Indians. We developed it for western patients who can afford it.” He called this sort…

Link to Full Article: Reverse-engineering artificial intelligence

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!